Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
6.38
-0.22 (-3.33%)
Apr 1, 2025, 4:00 PM EDT - Market closed
Kura Oncology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 224.46 | 37.32 | 51.8 | 90.67 | 325.49 | Upgrade
|
| Short-Term Investments | 502.93 | 386.64 | 386.18 | 427.29 | 307.83 | Upgrade
|
| Cash & Short-Term Investments | 727.4 | 423.96 | 437.99 | 517.96 | 633.32 | Upgrade
|
| Cash Growth | 71.57% | -3.20% | -15.44% | -18.21% | 167.35% | Upgrade
|
| Other Receivables | 6.1 | 1.1 | 0.9 | 1.4 | - | Upgrade
|
| Receivables | 6.1 | 1.1 | 0.9 | 1.4 | - | Upgrade
|
| Prepaid Expenses | 11.33 | 7.42 | 7.54 | 2.93 | 3.97 | Upgrade
|
| Total Current Assets | 744.83 | 432.48 | 446.43 | 522.29 | 637.29 | Upgrade
|
| Property, Plant & Equipment | 7.49 | 8.85 | 6.38 | 8.25 | 8.36 | Upgrade
|
| Other Long-Term Assets | 7.85 | 7.6 | 3.5 | 3.52 | 1.57 | Upgrade
|
| Total Assets | 760.16 | 448.94 | 456.31 | 534.05 | 647.21 | Upgrade
|
| Accounts Payable | 1.47 | 2.3 | 1.53 | 3.24 | 2.75 | Upgrade
|
| Accrued Expenses | 46.42 | 31.46 | 20.21 | 16.96 | 18.18 | Upgrade
|
| Current Portion of Long-Term Debt | 2.61 | - | - | - | 3 | Upgrade
|
| Current Portion of Leases | 1.88 | 1.51 | 2.32 | 2.26 | 2.09 | Upgrade
|
| Current Income Taxes Payable | 2.06 | - | - | - | - | Upgrade
|
| Current Unearned Revenue | 24.27 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 78.71 | 35.26 | 24.06 | 22.46 | 26.02 | Upgrade
|
| Long-Term Debt | 6.92 | 9.33 | 9.16 | - | 4.25 | Upgrade
|
| Long-Term Leases | 5.19 | 6.36 | 2.55 | 4.61 | 5.64 | Upgrade
|
| Long-Term Unearned Revenue | 253.91 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 1.8 | 0.71 | 0.27 | 0.38 | 0.4 | Upgrade
|
| Total Liabilities | 346.52 | 51.66 | 36.03 | 27.44 | 36.31 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 1,308 | 1,120 | 997.11 | 941.36 | 913.35 | Upgrade
|
| Retained Earnings | -895.42 | -721.44 | -568.81 | -432.97 | -302.5 | Upgrade
|
| Comprehensive Income & Other | 0.76 | -1.27 | -8.03 | -1.79 | 0.05 | Upgrade
|
| Shareholders' Equity | 413.64 | 397.27 | 420.28 | 506.61 | 610.91 | Upgrade
|
| Total Liabilities & Equity | 760.16 | 448.94 | 456.31 | 534.05 | 647.21 | Upgrade
|
| Total Debt | 16.59 | 17.2 | 14.02 | 6.88 | 14.98 | Upgrade
|
| Net Cash (Debt) | 710.8 | 406.76 | 423.96 | 511.09 | 618.34 | Upgrade
|
| Net Cash Growth | 74.75% | -4.06% | -17.05% | -17.35% | 169.85% | Upgrade
|
| Net Cash Per Share | 8.25 | 5.55 | 6.33 | 7.70 | 11.65 | Upgrade
|
| Filing Date Shares Outstanding | 80.75 | 76.14 | 68.44 | 66.61 | 66.21 | Upgrade
|
| Total Common Shares Outstanding | 78.23 | 74.35 | 68.31 | 66.57 | 66.19 | Upgrade
|
| Working Capital | 666.12 | 397.22 | 422.37 | 499.83 | 611.27 | Upgrade
|
| Book Value Per Share | 5.29 | 5.34 | 6.15 | 7.61 | 9.23 | Upgrade
|
| Tangible Book Value | 413.64 | 397.27 | 420.28 | 506.61 | 610.91 | Upgrade
|
| Tangible Book Value Per Share | 5.29 | 5.34 | 6.15 | 7.61 | 9.23 | Upgrade
|
| Machinery | 3.21 | 2.77 | 2.6 | 1.99 | 1.14 | Upgrade
|
| Leasehold Improvements | 1.74 | 1.54 | 1.54 | 1.53 | 1.17 | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.